361 Capital »

Amphastar Pharmaceuticals shares owned by 361 Capital

Quarter-by-quarter ownership of Amphastar Pharmaceuticals (AMPH) shares owned by 361 Capital from 13F filings

Historical chart of 361 Capital investment in Amphastar Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Amphastar Pharmaceuticals held by 361 Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Amphastar Pharmaceuticals by 361 Capital

Quarter filed Position value Share count Share price at filing
2020-06-30 $822k 37k 22.45

More positions owned by 361 Capital

Schwab International Equity Et Intl Eqty Etf (SCHF)
Schwab U.s. Tips Etf Us Tips Etf (SCHP)
Schwab Emerging Markets Equity Emrg Mkteq Etf (SCHE)
Spdr Blmbg Barclays Inv Grd Fl Blomberg Brc Inv (FLRN)
Schwab U.s. Large-cap Etf Us Lrg Cap Etf (SCHX)
Schwab U.s. Reit Etf Us Reit Etf (SCHH)
Schwab U.s. Mid Cap Etf Us Mid-cap Etf (SCHM)
Cadence Design Systems (CDNS)
Deckers Outdoor Corporation (DECK)
Berry Plastics (BERY)
Howmet Aerospace (HWM)
Clorox Company (CLX)
Lear Corp Com Cl A (LEA)
AutoZone (AZO)
Dish Network Corp Cl A

View all positions for 361 Capital

Top funds holding Amphastar Pharmaceuticals

Federated Investors
Vanguard Group
Neuberger Berman Group
Dimensional Fund Advisors
TD Asset Management
T. Rowe Price Associates
Boone Capital Management
Charles Schwab Investment Management
Mesirow Institutional Investment Management
Oberweis Asset Management
Nordea Investment Management Ab
Bessemer
Bank of New York Mellon
Voloridge Investment Management
LSV Asset Management

View all funds holding Amphastar Pharmaceuticals